To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene STK24TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
590 supporting clones for gene STK24 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA660023   .a 1 to 571 2 to 572   tiling clone, capped   571/571
(100 %)
1 diff
(99.9 %id)
AF339826   .a 457 to 2023 58 to 1624   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1567/1624
(96 %)
8 diff
(99.6 %id)
AA381235   .a 1323 to 1502 1 to 180       180/180
(100 %)
0 diff
(100 %id)
DA395717 thalamus .b 1 to 582 2 to 583   tiling clone, capped   582/585
(99 %)
1 diff
(99.9 %id)
NM_003576.3   .b 38 to 4576 1 to 4539 exact RefSeq,   4539/4539
(100 %)
1 diff
(100.0 %id)
DA386652 thalamus .b 39 to 627 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DA387320 thalamus .b 50 to 619 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA392328 thalamus .b 50 to 638 2 to 590   capped   589/590
(99 %)
0 diff
(100 %id)
DA388654 thalamus .b 78 to 662 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA531482 brain .b 82 to 641 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DB176441 kidney, tumor tissue .b 99 to 666 2 to 570   capped   569/572
(99 %)
2 diff
(99.7 %id)
AF083420 brain .b 127 to 2617 1 to 2491 exact tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2491/2491
(100 %)
5 diff
(99.8 %id)
DB174246 kidney, tumor tissue .b 159 to 712 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA391264 thalamus .b 256 to 831 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DB494698 hypothalamus .c 1 to 516 1 to 516   tiling clone,   516/516
(100 %)
9 diff
(98.3 %id)
CB996892 placenta, pre-eclamptic placenta .c 327 to 945 28 to 651   tiling clone,   624/822
(75 %)
29 diff
(96.5 %id)
CB993831 placenta, pre-eclamptic placenta .c 327 to 963 28 to 670   AAA   643/826
(77 %)
19 diff
(97.7 %id)
CR990328 T-Lymphocytes .c 332 to 730 1 to 399       399/476
(83 %)
1 diff
(99.8 %id)
DB479387 hippocampus .c 334 to 804 1 to 471       471/471
(100 %)
3 diff
(99.4 %id)
NM_001032296.2   .c 336 to 4959 1 to 4624 exact RefSeq,   4624/4624
(100 %)
1 diff
(100.0 %id)
BY799457 eye .c 340 to 671 1 to 332       332/332
(100 %)
5 diff
(98.5 %id)
AL553895 placenta, Placenta Cot 25-normalized .c 373 to 1275 1 to 897       897/909
(98 %)
7 diff
(99.3 %id)
BX403740 placenta .c 374 to 1473 1 to 1086       1086/1131
(96 %)
20 diff
(98.3 %id)
BX446920 neuroblastoma .c 374 to 1289 1 to 914       914/914
(100 %)
30 diff
(96.8 %id)
BM781703 Ascites, stomach .c 374 to 807 1 to 435       435/435
(100 %)
2 diff
(99.6 %id)
CT003629 T-Lymphocytes .c 382 to 733 1 to 352       352/519
(67 %)
1 diff
(99.9 %id)
BC065378 Ovary, teratocarcinoma .c 383 to 2999 1 to 2617 A395V available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2617/2617
(100 %)
3 diff
(99.9 %id)
BX462348 B cells (Ramos cell line) .c 383 to 1232 1 to 850       850/850
(100 %)
3 diff
(99.7 %id)
AL558579 T cells from T cell leukemia .c 383 to 1272 1 to 891       891/891
(100 %)
9 diff
(99.0 %id)
CR977642 T-Lymphocytes .c 383 to 865 1 to 483       483/485
(99 %)
4 diff
(99.2 %id)
BU849489 ovary, teratocarcinoma, cell line .c 384 to 1130 1 to 749       749/922
(81 %)
5 diff
(99.5 %id)
CR977869 T-Lymphocytes .c 385 to 868 1 to 484       484/484
(100 %)
5 diff
(99.0 %id)
CR988179 T-Lymphocytes .c 385 to 1009 1 to 626       626/626
(100 %)
2 diff
(99.7 %id)
CT001071 T-Lymphocytes .c 385 to 733 1 to 349       349/485
(71 %)
1 diff
(99.8 %id)
AL532795 adult brain, brain .c 386 to 1461 1 to 1062       911/1062
(85 %)
32 diff
(97.0 %id)
BC035578 Skin, melanotic melanoma. .c 390 to 3000 12 to 2622 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2611/2611
(100 %)
3 diff
(99.9 %id)
AL551073 placenta, Placenta Cot 25-normalized .c 390 to 1464 1 to 1062       1062/1071
(99 %)
26 diff
(97.6 %id)
BQ943915 carcinoma, cell line, Prostate .c 390 to 1280 1 to 895       893/931
(95 %)
14 diff
(98.5 %id)
BQ945481 carcinoma, cell line, Prostate .c 390 to 1287 1 to 904       904/907
(99 %)
16 diff
(98.3 %id)
BU542140 carcinoma, cell line, Prostate .c 390 to 1180 1 to 794       794/896
(88 %)
6 diff
(99.4 %id)
AL531979 brain, fetal liver, Liver, neuroblastoma cells .c 391 to 1286 1 to 891       891/891
(100 %)
11 diff
(98.8 %id)
BM472098 melanotic melanoma, skin .c 391 to 731 1 to 341       341/1359
(25 %)
4 diff
(99.8 %id)
CR993233 T-Lymphocytes .c 448 to 963 1 to 517       517/547
(94 %)
4 diff
(99.3 %id)
BM468548 leiomyosarcoma, uterus .c 545 to 1477 13 to 953       941/1074
(87 %)
21 diff
(98.1 %id)
DN994952 brain, whole brain .c 572 to 1132 1 to 561       561/561
(100 %)
4 diff
(99.3 %id)
DA525482 brain .c 612 to 1160 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
AF024636   .c 614 to 2582 1 to 1969 A402V     1969/1970
(99 %)
6 diff
(99.7 %id)
BT019619   .c 692 to 1985 1 to 1294       1294/1296
(99 %)
2 diff
(99.9 %id)
CR542227   .c 692 to 1984 1 to 1293       1293/1293
(100 %)
2 diff
(99.9 %id)
CV030827 mixed .c 692 to 1321 1 to 629       629/629
(100 %)
1 diff
(99.9 %id)
BQ889749 dorsal root ganglia .c 692 to 1537 1 to 848       848/849
(99 %)
5 diff
(99.5 %id)
CD358143 testis .c 696 to 1461 1 to 776       776/891
(87 %)
16 diff
(98.3 %id)
DB124643 thymus .c 723 to 1257 17 to 553   capped   537/552
(97 %)
7 diff
(98.8 %id)
BE896884 melanotic melanoma, skin .c 726 to 1249 27 to 555       530/555
(95 %)
14 diff
(97.5 %id)
TI_1948128110   .c 731 to 1292 168 to 728       561/1068
(52 %)
27 diff
(97.5 %id)
TI_1948128111   .c 731 to 1474 168 to 913       746/1245
(59 %)
11 diff
(99.2 %id)
TI_1948128445   .c 731 to 1425 165 to 860       696/1222
(56 %)
23 diff
(98.2 %id)
TI_1948128787   .c 731 to 1290 165 to 725       561/1186
(47 %)
23 diff
(98.1 %id)
TI_1948128788   .c 731 to 1478 165 to 915   AAA   751/1252
(59 %)
14 diff
(98.9 %id)
TI_1948129117   .c 731 to 1255 164 to 688       525/1147
(45 %)
18 diff
(98.5 %id)
AK300060 pericardium .c 733 to 2406 387 to 2060       1675/2060
(81 %)
9 diff
(99.6 %id)
BE869475 adenocarcinoma, colon .c 748 to 1474 1 to 720       720/791
(91 %)
11 diff
(98.7 %id)
BX642729   .c 754 to 1332 1 to 579       579/579
(100 %)
3 diff
(99.5 %id)
BM828056 Ascites, stomach .c 757 to 1383 1 to 627       627/627
(100 %)
1 diff
(99.9 %id)
BM472713 duodenal adenocarcinoma, cell line, small intestine .c 767 to 1575 1 to 812       812/1012
(80 %)
7 diff
(99.4 %id)
BU784176 insulinoma, Pancreas .c 768 to 1378 8 to 618       611/618
(98 %)
7 diff
(98.9 %id)
DA951910 Spleen .c 772 to 1336 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
CN266683 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 779 to 1013 1 to 235       235/235
(100 %)
0 diff
(100 %id)
BQ935628 large cell carcinoma, lung .c 792 to 1566 1 to 779       779/834
(93 %)
6 diff
(99.3 %id)
DA483305 brain .c 801 to 1269 193 to 661   capped   469/670
(70 %)
9 diff
(98.7 %id)
BG390412 embryonal carcinoma, cell line, testis .c 808 to 1449 1 to 648       648/1065
(60 %)
25 diff
(97.7 %id)
BP203399 coronary artery .c 816 to 1396 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
AU125024   .c 822 to 1575 2 to 756   capped   755/789
(95 %)
7 diff
(99.2 %id)
AA159193 Pancreas .c 823 to 1209 1 to 388   fully sequenced,   388/388
(100 %)
1 diff
(99.8 %id)
AW956953   .c 829 to 1418 1 to 590       590/609
(96 %)
3 diff
(99.6 %id)
DA760132   .c 834 to 1373 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DA382555 thalamus .c 835 to 1468 2 to 635   capped   634/634
(100 %)
0 diff
(100 %id)
DA382452 thalamus .c 878 to 1446 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
AU128958   .c 882 to 1353 2 to 473   capped   472/472
(100 %)
1 diff
(99.8 %id)
BP306364   .c 884 to 1454 1 to 571       571/571
(100 %)
3 diff
(99.5 %id)
BF527442 anaplastic oligodendroglioma with 1p/19qloss, brain .c 885 to 1624 1 to 741       741/953
(77 %)
8 diff
(99.2 %id)
BM708112 eye, RPE and Choroid .c 885 to 1386 1 to 502     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 502/502
(100 %)
1 diff
(99.9 %id)
BE546452 cervical carcinoma cell line, cervix .c 892 to 1547 1 to 650       650/650
(100 %)
10 diff
(98.5 %id)
BM741908 Ascites, stomach .c 894 to 1383 1 to 490       490/490
(100 %)
0 diff
(100 %id)
BP304726   .c 901 to 1474 1 to 574       574/583
(98 %)
0 diff
(100 %id)
CN266692 embryonic stem cells, cell lines H1, H7, andH9 .c 908 to 1535 1 to 628       628/628
(100 %)
4 diff
(99.4 %id)
DA158524 amygdala .c 920 to 1473 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB248277 uterus .c 920 to 1551 2 to 633   capped   632/632
(100 %)
0 diff
(100 %id)
BP239841 Liver .c 924 to 1529 4 to 610       607/610
(99 %)
7 diff
(98.9 %id)
AA135914 uterus .c 940 to 1375 1 to 436       436/436
(100 %)
2 diff
(99.6 %id)
BG386058 adenocarcinoma cell line, colon .c 958 to 1733 1 to 773       773/900
(85 %)
16 diff
(98.3 %id)
BG117834 adenocarcinoma, cell line, Liver .c 959 to 1621 1 to 662       666/953
(69 %)
20 diff
(98.0 %id)
BG328907 adenocarcinoma cell line, colon .c 959 to 1733 1 to 773       774/847
(91 %)
21 diff
(97.6 %id)
BM553036 amelanotic melanoma, cell line, skin .c 960 to 1813 1 to 854       854/1124
(75 %)
7 diff
(99.4 %id)
BQ932055 eye, normal pigmented retinal epithelium .c 961 to 1744 1 to 784       784/949
(82 %)
7 diff
(99.3 %id)
AL532026 brain, fetal liver, Liver, neuroblastoma cells .c 963 to 1800 1 to 839       839/839
(100 %)
3 diff
(99.7 %id)
CN266686 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 964 to 1717 1 to 754       754/754
(100 %)
0 diff
(100 %id)
BQ679213 melanotic melanoma, cell line, skin .c 966 to 1744 1 to 776       776/935
(82 %)
8 diff
(99.2 %id)
BQ682295 melanotic melanoma, cell line, skin .c 968 to 1868 1 to 904       904/906
(99 %)
11 diff
(98.8 %id)
BP221731 colon .c 969 to 1547 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
BE884947 leiomyosarcoma, uterus .c 970 to 1610 1 to 649       649/835
(77 %)
15 diff
(98.3 %id)
BE895687 melanotic melanoma, skin .c 972 to 1624 1 to 648       648/889
(72 %)
10 diff
(98.9 %id)
DA517764 brain .c 983 to 1474 2 to 493   capped   492/493
(99 %)
0 diff
(100 %id)
BM550136 astrocytoma grade IV, cell line, brain .c 1036 to 2036 27 to 1032       1006/1032
(97 %)
19 diff
(98.2 %id)
AU125424   .c 1037 to 1504 2 to 469   capped   468/805
(58 %)
1 diff
(99.9 %id)
BM741909 Ascites, stomach .c 1039 to 1669 1 to 631       631/631
(100 %)
1 diff
(99.9 %id)
DA666910   .c 1046 to 1595 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
CB150252 Liver .c 1055 to 1563 1 to 509       509/509
(100 %)
0 diff
(100 %id)
DA383395 thalamus .c 1062 to 1620 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA253301 caudate nucleus .c 1063 to 1604 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DB170394 kidney, tumor tissue .c 1064 to 1644 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BM757272 Ascites, stomach .c 1067 to 1585 1 to 519       519/519
(100 %)
0 diff
(100 %id)
BM741777 Ascites, stomach .c 1067 to 1691 1 to 625       625/625
(100 %)
0 diff
(100 %id)
BM788764 stomach .c 1067 to 1656 1 to 590       590/590
(100 %)
0 diff
(100 %id)
DB057430 testis .c 1067 to 1595 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
BI758251 brain .c 1068 to 1744 1 to 678       678/823
(82 %)
6 diff
(99.3 %id)
TI_57220844   .c 1068 to 1744 72 to 749       678/894
(75 %)
12 diff
(98.7 %id)
AU126296   .c 1072 to 1884 2 to 820   capped   819/892
(91 %)
27 diff
(97.0 %id)
DB084061 testis .c 1072 to 1626 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA821775 pericardium .c 1076 to 1646 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BP330826 rectum .c 1076 to 1657 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP290667 lung .c 1077 to 1656 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BM738346 Ascites, stomach .c 1077 to 1706 1 to 633       633/633
(100 %)
5 diff
(99.3 %id)
BP221658 colon .c 1080 to 1643 1 to 565       565/570
(99 %)
4 diff
(99.3 %id)
BP375547 uterus .c 1080 to 1660 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BI092242 cervix .c 1088 to 1742 1 to 652       652/652
(100 %)
3 diff
(99.6 %id)
CK002906 brain/CNS, Human Brain - Cerebellar Cortex .c 1090 to 1785 1 to 690       690/690
(100 %)
12 diff
(98.3 %id)
DA952602 Spleen .c 1091 to 1660 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
AA297126 embryo .c 1095 to 1362 1 to 271       271/271
(100 %)
7 diff
(97.5 %id)
DA130121 alzheimer cortex .c 1095 to 1737 2 to 644   capped   643/643
(100 %)
0 diff
(100 %id)
BP292603 lung .c 1107 to 1687 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DB120765 thymus .c 1109 to 1666 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BI868225 adenocarcinoma, cell line, Liver .c 1119 to 1815 1 to 698       698/942
(74 %)
5 diff
(99.5 %id)
TI_57227880   .c 1119 to 1815 52 to 749       698/942
(74 %)
5 diff
(99.5 %id)
DA716696   .c 1119 to 1671 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
BE537025 cervix .c 1125 to 1804 19 to 693       679/906
(74 %)
29 diff
(96.8 %id)
BM741199 Ascites, stomach .c 1125 to 1729 1 to 605       605/605
(100 %)
0 diff
(100 %id)
BM756873 Ascites, stomach .c 1125 to 1744 1 to 619       619/621
(99 %)
3 diff
(99.6 %id)
DA951254 Spleen .c 1125 to 1690 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
BP326357 prostata .c 1126 to 1472 1 to 347       347/556
(62 %)
4 diff
(99.3 %id)
DA130925 alzheimer cortex .c 1127 to 1658 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
BM457481 embryonal carcinoma, cell line, testis .c 1127 to 1953 29 to 855       827/1062
(77 %)
15 diff
(98.6 %id)
TI_1948128448   .c 1129 to 1986 984 to 129       856/1115
(76 %)
24 diff
(97.9 %id)
AU120284 whole embryo, mainly body .c 1130 to 1813 2 to 685   capped   684/757
(90 %)
5 diff
(99.4 %id)
AA007238 whole brain .c 1131 to 1430 1 to 300       300/300
(100 %)
0 diff
(100 %id)
TI_1948128113   .c 1133 to 1986 971 to 126       846/1111
(76 %)
32 diff
(97.2 %id)
H06969 whole brain .c 1138 to 1474 1 to 340       340/486
(69 %)
5 diff
(99.0 %id)
CF141471 CNCAP(3)T-225 cell line, Prostate .c 1138 to 1688 8 to 558       551/558
(98 %)
6 diff
(99.0 %id)
TI_154172206   .c 1138 to 1744 80 to 686       607/609
(99 %)
1 diff
(99.9 %id)
BX452596 adult brain, brain .c 1151 to 1744 1 to 596       596/822
(72 %)
12 diff
(98.6 %id)
DA602732   .c 1163 to 1722 2 to 561   capped   560/561
(99 %)
1 diff
(99.9 %id)
CN266691 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1176 to 1925 1 to 750       750/750
(100 %)
3 diff
(99.6 %id)
AA160782 Pancreas .c 1179 to 1682 501 to 1   fully sequenced,   501/501
(100 %)
3 diff
(99.5 %id)
AA298486 Prostate .c 1188 to 1380 1 to 193       193/193
(100 %)
0 diff
(100 %id)
R52999 whole brain .c 1191 to 1619 1 to 435       435/455
(95 %)
9 diff
(98.1 %id)
W44758 Pancreas, pancreatic islet .c 1217 to 1617 1 to 409       409/424
(96 %)
9 diff
(97.9 %id)
BQ687165 ductal carcinoma, cell line, Pancreas .c 1217 to 1949 22 to 754       733/935
(78 %)
21 diff
(97.8 %id)
BE779589 eye, retinoblastoma .c 1218 to 1880 1 to 661       661/835
(79 %)
12 diff
(98.6 %id)
BF381870 brain, primitive neuroectoderm .c 1218 to 1909 1 to 686       623/878
(70 %)
29 diff
(96.7 %id)
BQ064648 lymph, lymphoma, cell line .c 1220 to 2109 1 to 904       904/987
(91 %)
31 diff
(96.9 %id)
TI_1948129120   .c 1225 to 1986 886 to 125       762/1098
(69 %)
16 diff
(98.6 %id)
BG391299 embryonal carcinoma, cell line, testis .c 1229 to 1961 1 to 731       731/1139
(64 %)
18 diff
(98.5 %id)
R19759 whole brain .c 1243 to 1384 1 to 142     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 142/151
(94 %)
2 diff
(98.7 %id)
BM741080 Ascites, stomach .c 1262 to 1401 1 to 140       140/140
(100 %)
0 diff
(100 %id)
BE872209 adenocarcinoma, colon .c 1279 to 1742 1 to 472       472/566
(83 %)
13 diff
(97.8 %id)
TI_1948128790   .c 1288 to 1986 827 to 127       701/1136
(61 %)
15 diff
(98.7 %id)
CN266685 embryonic stem cells, cell lines H1, H7, andH9 .c 1293 to 1805 1 to 514       514/514
(100 %)
5 diff
(99.1 %id)
TI_1948128447   .c 1305 to 1986 808 to 123       686/1484
(46 %)
28 diff
(98.2 %id)
TI_1948128789   .c 1306 to 1986 807 to 124       684/1460
(46 %)
30 diff
(98.0 %id)
BG110664 Bone, osteosarcoma, cell line .c 1314 to 1964 1 to 650       650/650
(100 %)
2 diff
(99.7 %id)
CB129473 Liver .c 1314 to 1881 1 to 567       567/567
(100 %)
2 diff
(99.7 %id)
BP377289 uterus .c 1315 to 1896 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DA428837 colon .c 1316 to 1880 2 to 567   capped   566/569
(99 %)
3 diff
(99.5 %id)
CR594698 T cells (Jurkat cell line) .c 1322 to 2506 1 to 1185   tiling clone,   1185/1185
(100 %)
0 diff
(100 %id)
BX405230 T cells (Jurkat cell line) .c 1322 to 1844 1 to 523   fully sequenced,   523/523
(100 %)
2 diff
(99.7 %id)
BM755993 Ascites, stomach .c 1330 to 1608 1 to 279       279/279
(100 %)
3 diff
(99.0 %id)
DA668402 esophagus .c 1333 to 1852 2 to 526   capped   525/527
(99 %)
8 diff
(98.5 %id)
AA425511   .c 1341 to 1813 1 to 473       473/483
(97 %)
2 diff
(99.6 %id)
DA541530 lung .c 1344 to 1929 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
TI_1948128112   .c 1348 to 1986 764 to 125       640/1463
(43 %)
13 diff
(99.2 %id)
AL576769 placenta, Placenta Cot 25-normalized .c 1358 to 2309 960 to 9       952/968
(98 %)
5 diff
(99.5 %id)
H87570 placenta .c 1360 to 1795 1 to 450       448/450
(99 %)
25 diff
(94.5 %id)
TI_1948129119   .c 1366 to 1986 742 to 122       621/1414
(43 %)
9 diff
(99.4 %id)
BQ722346 sympathetic trunk .c 1370 to 2225 38 to 894       857/895
(95 %)
21 diff
(97.7 %id)
CD654116 Embryonic Stem cells .c 1375 to 2137 8 to 755       748/786
(95 %)
25 diff
(96.9 %id)
CA396314 eye, RPE/choroid .c 1386 to 2001 1 to 616       616/616
(100 %)
2 diff
(99.7 %id)
H11876 whole brain .c 1399 to 1735 1 to 337     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 337/337
(100 %)
0 diff
(100 %id)
BQ232644 melanotic melanoma, skin .c 1399 to 2033 1 to 643       643/951
(67 %)
20 diff
(97.9 %id)
CB121945 Liver .c 1400 to 1813 1 to 414       414/419
(98 %)
2 diff
(99.6 %id)
AW387773 stomach .c 1403 to 1877 1 to 475       475/475
(100 %)
6 diff
(98.8 %id)
CB128005 cervix, Uterine .c 1420 to 2075 1 to 655       655/655
(100 %)
2 diff
(99.7 %id)
CK000374 mixed .c 1427 to 2212 1 to 787       787/787
(100 %)
11 diff
(98.7 %id)
BM479282 duodenal adenocarcinoma, cell line, small intestine .c 1430 to 2223 1 to 799       799/1136
(70 %)
22 diff
(98.1 %id)
CF272222 Brain glioblastoma .c 1430 to 2343 1 to 919       919/944
(97 %)
10 diff
(99.0 %id)
BE787066 large cell carcinoma, lung .c 1432 to 1966 1 to 533       533/533
(100 %)
3 diff
(99.5 %id)
BG613817 embryonal carcinoma, testis .c 1432 to 2181 1 to 749       749/753
(99 %)
14 diff
(98.2 %id)
BE785418 large cell carcinoma, lung .c 1455 to 2009 1 to 570       570/1029
(55 %)
35 diff
(96.6 %id)
CX868483 embryonic stem .c 1466 to 2178 1 to 713     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 713/713
(100 %)
1 diff
(99.9 %id)
H48864 liver and spleen .c 1468 to 1930 12 to 476       465/478
(97 %)
15 diff
(96.9 %id)
AA007239 whole brain .c 1475 to 1758 7 to 293       287/293
(97 %)
3 diff
(99.0 %id)
CV369247 head_neck .c 1478 to 1602 1 to 127       127/127
(100 %)
12 diff
(90.6 %id)
CV369311 head_neck .c 1478 to 1602 1 to 127       127/127
(100 %)
12 diff
(90.6 %id)
BP261297 small intestine .c 1497 to 2079 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
W81539 heart .c 1502 to 1926 1 to 428       428/428
(100 %)
13 diff
(97.0 %id)
N46960 liver and spleen .c 1509 to 1813 1 to 308       308/367
(83 %)
8 diff
(97.9 %id)
CN266687 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1513 to 2167 1 to 655       655/655
(100 %)
1 diff
(99.9 %id)
CN266688 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1513 to 2225 1 to 714       714/714
(100 %)
3 diff
(99.6 %id)
BP225694   .c 1514 to 2096 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DA430122 colon .c 1515 to 2012 2 to 499   capped   498/498
(100 %)
2 diff
(99.6 %id)
CR748149   .c 1516 to 1666 18 to 168       151/171
(88 %)
9 diff
(94.8 %id)
DA199527 brain .c 1517 to 2100 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
AA281138 germinal center B cell .c 1527 to 1758 1 to 232       232/232
(100 %)
0 diff
(100 %id)
CX868948 embryonic stem .c 1527 to 2322 1 to 796       796/796
(100 %)
3 diff
(99.7 %id)
CN266690 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1532 to 2159 1 to 631       631/631
(100 %)
3 diff
(99.6 %id)
CX869960 embryonic stem .c 1533 to 2214 1 to 682       682/682
(100 %)
1 diff
(99.9 %id)
BG680559 skin, squamous cell carcinoma .c 1546 to 2378 1 to 833       833/833
(100 %)
6 diff
(99.3 %id)
BU957326 adenocarcinoma, cell line, breast .c 1548 to 2343 1 to 809       809/850
(95 %)
28 diff
(96.8 %id)
CX870980 embryonic stem .c 1550 to 2242 1 to 693       693/693
(100 %)
1 diff
(99.9 %id)
CR986274 T-Lymphocytes .c 1553 to 2392 1 to 848       848/853
(99 %)
11 diff
(98.8 %id)
BI871450 adenocarcinoma, cell line, Liver .c 1564 to 2398 1 to 844       844/845
(99 %)
34 diff
(96.0 %id)
TI_57230160   .c 1564 to 2398 91 to 934       844/845
(99 %)
34 diff
(96.0 %id)
N31140 melanocyte .c 1572 to 2066 1 to 496       496/498
(99 %)
7 diff
(98.6 %id)
N36365 melanocyte .c 1572 to 1953 1 to 382       382/461
(82 %)
7 diff
(98.5 %id)
BE549327 cervical carcinoma cell line, cervix .c 1626 to 2338 1 to 703       703/703
(100 %)
16 diff
(97.8 %id)
BG104847 adrenal cortex carcinoma, cell line, adrenal gland .c 1653 to 2401 1 to 739       739/950
(77 %)
29 diff
(97.0 %id)
N44256 melanocyte .c 1669 to 2134 1 to 467       467/467
(100 %)
5 diff
(99.0 %id)
BM687644 eye, eye anterior segment .c 1669 to 2190 9 to 530       522/534
(97 %)
9 diff
(98.4 %id)
T32342 Kidney .c 1671 to 1953 1 to 284     Submitted on the opposite strand 284/294
(96 %)
5 diff
(98.3 %id)
AW402550 lymph .c 1700 to 2191 1 to 498       504/498
(101 %)
10 diff
(98.0 %id)
TI_154138946   .c 1701 to 2208 81 to 588       508/511
(99 %)
3 diff
(99.5 %id)
C06322   .c 1726 to 1886 1 to 157       157/185
(84 %)
11 diff
(94.1 %id)
BI085335 astrocytoma grade IV, cell line, brain .c 1728 to 2429 1 to 703       703/703
(100 %)
10 diff
(98.6 %id)
BI258994 cervical carcinoma cell line, cervix .c 1730 to 2306 1 to 576       576/576
(100 %)
8 diff
(98.7 %id)
BX411683 placenta .c 1745 to 2345 603 to 6       598/887
(67 %)
6 diff
(99.4 %id)
BI256513 cervical carcinoma cell line, cervix .c 1745 to 2601 1 to 860       860/911
(94 %)
23 diff
(97.5 %id)
T19491   .c 1757 to 2175 1 to 420       420/420
(100 %)
4 diff
(99.1 %id)
DA125651 cerebellum .c 1777 to 2346 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BG397327 B-cells, primary B-cells from tonsils (cell line) .c 1779 to 2522 1 to 763       763/763
(100 %)
45 diff
(94.2 %id)
CA453315 mixed (pool of 40 RNAs) .c 1780 to 2529 1 to 758       758/764
(99 %)
19 diff
(97.6 %id)
BX405229 T cells (Jurkat cell line) .c 1783 to 2506 724 to 1   fully sequenced,   724/724
(100 %)
6 diff
(99.2 %id)
CA308254 Alveolar Macrophage, lung .c 1786 to 2535 768 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 750/750
(100 %)
5 diff
(99.4 %id)
AL574746 placenta, Placenta Cot 25-normalized .c 1800 to 2782 1000 to 15       986/1158
(85 %)
6 diff
(99.5 %id)
N26337 melanocyte .c 1808 to 2277 1 to 474       479/474
(101 %)
12 diff
(97.5 %id)
CN478931 Human Lung Epithelial cells, lung .c 1808 to 2535 742 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 726/726
(100 %)
2 diff
(99.8 %id)
BE043983 lymph node, lymphoma, follicular mixed small and largecell .c 1812 to 2348 536 to 1       536/570
(94 %)
24 diff
(95.8 %id)
TI_227715274   .c 1812 to 2535 821 to 98   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 724/944
(76 %)
8 diff
(99.2 %id)
CR738868 Kidney .c 1814 to 2482 1 to 669       669/669
(100 %)
0 diff
(100 %id)
Z45569 brain, total brain .c 1822 to 2218 1 to 397       397/397
(100 %)
0 diff
(100 %id)
BG988415 head_neck .c 1838 to 2034 22 to 216       195/223
(87 %)
10 diff
(95.6 %id)
AI199853 placenta .c 1838 to 2348 511 to 1       511/511
(100 %)
3 diff
(99.5 %id)
AA708716 uterus .c 1847 to 2275 449 to 21       429/449
(95 %)
0 diff
(100 %id)
BG259367 embryonal carcinoma, cell line, testis .c 1852 to 2608 1 to 745       745/943
(79 %)
17 diff
(98.2 %id)
BU620405 cell lines, Chondrosarcoma .c 1866 to 2535 687 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 669/669
(100 %)
1 diff
(99.9 %id)
AA304889 retina .c 1872 to 2261 1 to 392       392/392
(100 %)
2 diff
(99.5 %id)
AW978414   .c 1880 to 2275 412 to 17     Submitted on the opposite strand 396/421
(94 %)
7 diff
(98.4 %id)
BM992942 lung, Metastatic Chondrosarcoma .c 1881 to 2275 424 to 30   AAA   395/406
(97 %)
0 diff
(100 %id)
BU619871 Cell Line, Chondrosarcoma .c 1883 to 2533 670 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 652/652
(100 %)
1 diff
(99.9 %id)
BE697346 colon .c 1884 to 2194 1 to 307       307/307
(100 %)
7 diff
(97.8 %id)
DA863530 placenta .c 1885 to 2440 2 to 558   capped   557/557
(100 %)
3 diff
(99.5 %id)
BU731964 eye, RPE and Choroid .c 1885 to 2533 666 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 648/648
(100 %)
1 diff
(99.9 %id)
CB529348 Aveolar Macrophage, lung .c 1885 to 2535 667 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 651/651
(100 %)
2 diff
(99.7 %id)
BQ269411 Pancreas, Purified pancreatic islet .c 1894 to 2461 12 to 579   fully sequenced,   568/579
(98 %)
6 diff
(99.0 %id)
BQ269412 Pancreas, Purified pancreatic islet .c 1894 to 2400 11 to 517       507/517
(98 %)
6 diff
(98.9 %id)
AA828428 germinal center B cell .c 1905 to 2275 404 to 33       372/404
(92 %)
0 diff
(100 %id)
BF216748 brain, glioblastoma .c 1913 to 2635 1 to 703       703/839
(83 %)
44 diff
(94.8 %id)
BQ771731 Chondrosarcoma Grade II, Left Pelvis .c 1914 to 2537 640 to 17       624/640
(97 %)
0 diff
(100 %id)
BG253936 adenocarcinoma, cell line, Prostate .c 1927 to 2702 1 to 769       769/968
(79 %)
15 diff
(98.5 %id)
CK825744 Pancreas, Purified pancreatic islet .c 1935 to 2508 1 to 574     Submitted on the opposite strand 574/574
(100 %)
0 diff
(100 %id)
BX411494 adult brain, brain .c 1950 to 2329 399 to 20       380/399
(95 %)
0 diff
(100 %id)
AL564971 adult brain, brain .c 1962 to 2964 994 to 1       994/999
(99 %)
11 diff
(98.9 %id)
CN266684 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1968 to 2698 1 to 733       733/733
(100 %)
3 diff
(99.6 %id)
N42390 melanocyte .c 1968 to 2456 1 to 486       486/487
(99 %)
7 diff
(98.6 %id)
CD365754 Alveolar Macrophage, lung .c 1977 to 2535 577 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 559/559
(100 %)
2 diff
(99.7 %id)
BG539319 lung .c 1999 to 2726 1 to 718       718/915
(78 %)
28 diff
(97.0 %id)
BF570190.
matches multiple genes
Kidney, renal carcinoma (ascites) .c 2005 to 2772 777 to 13     also hits gene fleedar 765/994
(76 %)
0 diff
(100 %id)
AA846396   .c 2007 to 2348 344 to 3       342/344
(99 %)
0 diff
(100 %id)
BG013768 placenta_normal .c 2022 to 2344 1 to 323       323/323
(100 %)
5 diff
(98.5 %id)
CB145022 Liver .c 2022 to 2458 1 to 437       437/437
(100 %)
1 diff
(99.8 %id)
TI_154030435   .c 2024 to 2998 1037 to 67   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 971/990
(98 %)
4 diff
(99.6 %id)
AL558578 T cells from T cell leukemia .c 2025 to 2968 944 to 1       944/944
(100 %)
12 diff
(98.8 %id)
H87462 placenta .c 2029 to 2333 306 to 1       306/306
(100 %)
2 diff
(99.4 %id)
R76027 placenta .c 2032 to 2314 1 to 285       285/381
(74 %)
5 diff
(98.7 %id)
AL545454 placenta, Placenta Cot 25-normalized .c 2034 to 2828 1 to 795       795/795
(100 %)
2 diff
(99.8 %id)
BU783907 insulinoma, Pancreas .c 2035 to 2527 489 to 1       489/489
(100 %)
2 diff
(99.6 %id)
BG435355 placenta .c 2037 to 2724 1 to 694       694/730
(95 %)
9 diff
(98.8 %id)
AA860516 parathyroid gland, parathyroid tumor .c 2046 to 2537 494 to 7       488/494
(98 %)
0 diff
(100 %id)
BM690173 eye, human retina .c 2053 to 2560 1 to 508     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 508/508
(100 %)
6 diff
(98.9 %id)
T19490   .c 2055 to 2188 132 to 1       132/132
(100 %)
7 diff
(94.7 %id)
CK003633 brain/CNS, Human Brain - Cerebellar Cortex .c 2055 to 2755 1 to 700       700/701
(99 %)
23 diff
(96.8 %id)
CR601729 Placenta Cot 25-normalized .c 2059 to 2976 1 to 918       918/918
(100 %)
0 diff
(100 %id)
AL549555 placenta, Placenta Cot 25-normalized .c 2059 to 2988 1 to 929       929/932
(99 %)
12 diff
(98.8 %id)
AL532025 brain, fetal liver, Liver, neuroblastoma cells .c 2077 to 2970 895 to 1       895/895
(100 %)
5 diff
(99.5 %id)
CN266689 embryonic stem cells, cell lines H1, H7, andH9 .c 2082 to 2752 1 to 672       672/672
(100 %)
3 diff
(99.6 %id)
AI376905   .c 2089 to 2275 216 to 30       187/216
(86 %)
0 diff
(100 %id)
CR615038 Neuroblastoma Cot 25-normalized .c 2091 to 2976 1 to 886       886/886
(100 %)
0 diff
(100 %id)
BX324448 Neuroblastoma Cot 25-normalized .c 2091 to 2959 1 to 869       869/869
(100 %)
1 diff
(99.9 %id)
BX324449 Neuroblastoma Cot 25-normalized .c 2091 to 2992 1 to 901       901/901
(100 %)
6 diff
(99.4 %id)
TI_149315289   .c 2092 to 3000 983 to 84   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 900/1008
(89 %)
20 diff
(98.1 %id)
BX387453 Neuroblastoma Cot 25-normalized .c 2094 to 2976 883 to 1       883/885
(99 %)
29 diff
(96.8 %id)
AW291995   .c 2109 to 2535 442 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 427/427
(100 %)
0 diff
(100 %id)
AA779770   .c 2114 to 2537 425 to 2       424/425
(99 %)
0 diff
(100 %id)
AA425401   .c 2115 to 2537 424 to 2       423/424
(99 %)
0 diff
(100 %id)
AA281738 germinal center B cell .c 2118 to 2489 372 to 1       372/372
(100 %)
0 diff
(100 %id)
BM803019 duodenal adenocarcinoma, cell line, small intestine .c 2118 to 2962 11 to 857       847/1043
(81 %)
12 diff
(98.9 %id)
AA724135 parathyroid gland, parathyroid tumor .c 2120 to 2587 473 to 7       467/473
(98 %)
0 diff
(100 %id)
AA586774 colon, colon tumor RER+ .c 2125 to 2534 410 to 1       410/410
(100 %)
0 diff
(100 %id)
FN107996 breast carcinoma .c 2126 to 2184 1 to 60       60/61
(98 %)
5 diff
(91.9 %id)
AA977538 Kidney .c 2126 to 2535 408 to 1       408/408
(100 %)
3 diff
(99.3 %id)
BI919244 brain .c 2130 to 2935 29 to 845       817/871
(93 %)
32 diff
(96.4 %id)
TI_57243782   .c 2130 to 2935 29 to 845       817/871
(93 %)
32 diff
(96.4 %id)
BE071312 breast .c 2132 to 2301 181 to 12     Submitted on the opposite strand 170/181
(93 %)
0 diff
(100 %id)
AL135267 melanoma (MeWo cell line) .c 2135 to 2547 1 to 413       413/413
(100 %)
0 diff
(100 %id)
BI258165 cervical carcinoma cell line, cervix .c 2136 to 2888 1 to 744       744/744
(100 %)
15 diff
(98.0 %id)
BE673607 carcinoid, lung .c 2144 to 2275 161 to 30       132/161
(81 %)
0 diff
(100 %id)
AI499465 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 2145 to 2537 393 to 1       393/393
(100 %)
0 diff
(100 %id)
TI_227714194   .c 2165 to 3000 919 to 96   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 824/927
(88 %)
30 diff
(96.8 %id)
AA730464 Ewing's sarcoma .c 2170 to 2610 8 to 448       441/448
(98 %)
6 diff
(98.7 %id)
BG165614 hypernephroma, cell line, Kidney .c 2170 to 2765 1 to 591       591/915
(64 %)
36 diff
(96.1 %id)
CD105780 brain, Pituitary .c 2171 to 2992 1 to 822       822/822
(100 %)
0 diff
(100 %id)
TI_154102199   .c 2197 to 3000 879 to 79   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 801/955
(83 %)
15 diff
(98.5 %id)
TI_149300098   .c 2200 to 3000 861 to 68   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 794/794
(100 %)
32 diff
(96.0 %id)
AA761234 germinal center B cell .c 2202 to 2538 358 to 24       335/358
(93 %)
0 diff
(100 %id)
TI_149297193   .c 2217 to 2999 868 to 89   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 780/938
(83 %)
10 diff
(99.0 %id)
AI347809 2 pooled tumors (clear cell type), Kidney .c 2219 to 2494 1 to 275     Submitted on the opposite strand 275/275
(100 %)
5 diff
(98.2 %id)
BF037217 adenocarcinoma, ovary .c 2224 to 2999 777 to 1     Submitted on the opposite strand 777/875
(88 %)
20 diff
(97.8 %id)
BQ083750 stomach .c 2225 to 2587 1 to 362       362/362
(100 %)
2 diff
(99.5 %id)
BQ084445 stomach .c 2225 to 2433 1 to 208       208/210
(99 %)
2 diff
(99.1 %id)
AA243393 germinal center B cell .c 2231 to 2683 1 to 454       454/454
(100 %)
3 diff
(99.4 %id)
TI_149313819   .c 2232 to 3000 853 to 88   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 766/940
(81 %)
5 diff
(99.5 %id)
AA630114 lung .c 2242 to 2532 290 to 1       290/290
(100 %)
1 diff
(99.7 %id)
DA391134 thalamus .c 2243 to 2838 2 to 596   capped   595/595
(100 %)
2 diff
(99.7 %id)
H81892 melanocyte .c 2245 to 2640 1 to 398       398/400
(99 %)
9 diff
(97.8 %id)
N44226 melanocyte .c 2245 to 2490 1 to 249       249/255
(97 %)
6 diff
(97.7 %id)
W90336 liver and spleen .c 2245 to 2676 1 to 433   fully sequenced,   433/433
(100 %)
3 diff
(99.4 %id)
BM830373 stomach .c 2246 to 2845 1 to 598       598/598
(100 %)
3 diff
(99.5 %id)
AA876765 metastatic prostate bone lesion .c 2247 to 2533 1 to 287   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 287/287
(100 %)
3 diff
(99.0 %id)
CA445431 Chondrosarcoma, Left Pubic Bone .c 2247 to 3000 772 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 754/754
(100 %)
3 diff
(99.7 %id)
AA332383 Embryo, 8 weeks .c 2248 to 2691 1 to 454       454/454
(100 %)
11 diff
(97.6 %id)
TI_149283682   .c 2248 to 3000 839 to 87   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 753/1101
(68 %)
59 diff
(94.7 %id)
AI696203 pooled germ cell tumors .c 2249 to 2537 296 to 7       290/296
(97 %)
0 diff
(100 %id)
CX784622 human embryonic stem cells .c 2249 to 2982 1 to 734       734/734
(100 %)
0 diff
(100 %id)
TI_154002111   .c 2249 to 2828 666 to 82   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 585/585
(100 %)
20 diff
(96.6 %id)
CA442517 Fibrosarcoma .c 2249 to 2998 767 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 749/749
(100 %)
1 diff
(99.9 %id)
BU944714 adenocarcinoma, cell line, breast .c 2251 to 2998 1 to 748       748/932
(80 %)
3 diff
(99.7 %id)
CB529935 Aveolar Macrophage, lung .c 2251 to 3000 767 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 749/749
(100 %)
1 diff
(99.9 %id)
BF438958 pooled .c 2257 to 2534 280 to 3       278/280
(99 %)
0 diff
(100 %id)
BE709286 head_neck .c 2265 to 2391 138 to 16       123/138
(89 %)
0 diff
(100 %id)
TI_154105047   .c 2267 to 3000 810 to 79   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 732/732
(100 %)
11 diff
(98.5 %id)
W07593 lung .c 2270 to 2642 1 to 379   fully sequenced,   379/379
(100 %)
9 diff
(97.7 %id)
TI_149287581   .c 2278 to 2998 780 to 62   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 719/1071
(67 %)
3 diff
(99.8 %id)
BM982223 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 2278 to 2999 740 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 722/722
(100 %)
0 diff
(100 %id)
BM972877 lung .c 2280 to 2998 735 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 717/717
(100 %)
3 diff
(99.6 %id)
CB305664 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 2282 to 3000 737 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 719/719
(100 %)
0 diff
(100 %id)
W39345 parathyroid gland, parathyroid tumor .c 2286 to 2662 1 to 383   fully sequenced,   383/383
(100 %)
6 diff
(98.5 %id)
DA504406 brain .c 2287 to 2857 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BG250596 adenocarcinoma, cell line, Liver .c 2289 to 2999 707 to 1     Submitted on the opposite strand 707/964
(73 %)
12 diff
(98.8 %id)
TI_149292463   .c 2298 to 3000 784 to 87   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 698/923
(75 %)
13 diff
(98.6 %id)
AW750969 colon .c 2307 to 2864 559 to 2       558/559
(99 %)
0 diff
(100 %id)
BE140212 head_neck .c 2307 to 2864 559 to 2     Submitted on the opposite strand 558/559
(99 %)
0 diff
(100 %id)
H96960 pineal gland .c 2310 to 2729 7 to 435       429/443
(96 %)
16 diff
(96.4 %id)
BF684889 leiomyosarcoma cell line, uterus .c 2312 to 2990 1 to 666       666/959
(69 %)
20 diff
(98.0 %id)
BG913913 anaplastic oligodendroglioma with 1p/19qloss, brain .c 2313 to 3008 1 to 700       700/843
(83 %)
13 diff
(98.5 %id)
CA432228 cell lines, Enchondroma .c 2313 to 3000 706 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 688/688
(100 %)
0 diff
(100 %id)
BU622498 cell lines, Chondrosarcoma .c 2313 to 2999 705 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 687/687
(100 %)
3 diff
(99.6 %id)
AA411405 ovarian tumor, ovary .c 2317 to 2535 218 to 1       218/218
(100 %)
1 diff
(99.6 %id)
TI_149274258   .c 2325 to 2998 761 to 88   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 674/1020
(66 %)
5 diff
(99.6 %id)
BM968437 lung, Primary Lung Epithelial Cells .c 2325 to 2998 692 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 674/675
(99 %)
5 diff
(99.3 %id)
BQ045196 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 2329 to 3000 690 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 672/672
(100 %)
0 diff
(100 %id)
BU960885 mixed (pool of 40 RNAs) .c 2331 to 2828 1 to 498       498/498
(100 %)
2 diff
(99.6 %id)
BU629256 cell lines, Chondrosarcoma .c 2332 to 2998 685 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 667/667
(100 %)
0 diff
(100 %id)
AI720649 colon .c 2341 to 2535 195 to 1       195/195
(100 %)
0 diff
(100 %id)
AI683172 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 2347 to 2829 485 to 3       483/485
(99 %)
0 diff
(100 %id)
BU627611 Bone, Enchondroma cell line .c 2347 to 3000 673 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 655/655
(100 %)
1 diff
(99.9 %id)
CX867715 embryonic stem .c 2355 to 3000 1 to 646   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 646/646
(100 %)
0 diff
(100 %id)
AI743983 Kidney .c 2359 to 2533 197 to 23   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 175/175
(100 %)
1 diff
(99.5 %id)
AW235683 Kidney .c 2359 to 2533 195 to 21   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 175/175
(100 %)
4 diff
(97.8 %id)
CA446335 Chondrosarcoma, Left Pubic Bone .c 2360 to 3000 660 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 642/645
(99 %)
3 diff
(99.6 %id)
BQ772923 Chondrosarcoma Cell line .c 2364 to 3000 655 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 637/637
(100 %)
0 diff
(100 %id)
AV749534 Pituitary .c 2365 to 2503 1 to 135       135/142
(95 %)
6 diff
(95.8 %id)
CR607724 Placenta Cot 25-normalized .c 2367 to 3001 1 to 635   tiling clone,   635/635
(100 %)
0 diff
(100 %id)
BX360464 Placenta Cot 25-normalized .c 2367 to 3001 1 to 636       636/636
(100 %)
36 diff
(94.4 %id)
BX330592 Placenta Cot 25-normalized .c 2368 to 2998 631 to 1       631/631
(100 %)
18 diff
(97.2 %id)
DB179099 kidney, tumor tissue .c 2372 to 2931 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
BU682411 lung .c 2380 to 3000 639 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 621/621
(100 %)
0 diff
(100 %id)
EL952846 eyeball .c 2381 to 2999 12 to 630   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 619/630
(98 %)
6 diff
(99.1 %id)
CD364909 Alveolar Macrophage, lung .c 2383 to 3000 636 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 618/618
(100 %)
2 diff
(99.7 %id)
BE832475 marrow .c 2385 to 2623 340 to 101       240/340
(70 %)
0 diff
(100 %id)
CA433210 mixed .c 2385 to 2828 462 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 444/444
(100 %)
5 diff
(98.9 %id)
BQ015763 lung, Metastatic Chondrosarcoma .c 2389 to 3000 630 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 612/612
(100 %)
3 diff
(99.6 %id)
AW242074 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 2391 to 2829 440 to 2       439/440
(99 %)
0 diff
(100 %id)
BX433850 neuroblastoma .c 2392 to 2981 590 to 1       590/751
(78 %)
14 diff
(98.2 %id)
DB518054 testis .c 2398 to 2828 1 to 433     Submitted on the opposite strand 433/433
(100 %)
5 diff
(98.9 %id)
AW273790 lung, two pooled squamous cell carcinomas .c 2399 to 2833 440 to 6       435/440
(98 %)
0 diff
(100 %id)
BQ286054 Pancreas, Purified pancreatic islet .c 2399 to 3001 604 to 2       603/604
(99 %)
0 diff
(100 %id)
CA435889 lung, Metastatic Chondrosarcoma .c 2411 to 2998 606 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 588/588
(100 %)
0 diff
(100 %id)
BM976247 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 2414 to 3000 605 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 587/587
(100 %)
4 diff
(99.4 %id)
FN107215 breast carcinoma .c 2424 to 2531 109 to 1     Submitted on the opposite strand 109/109
(100 %)
5 diff
(95.5 %id)
EL951844 eyeball .c 2426 to 2997 1 to 572       572/572
(100 %)
4 diff
(99.4 %id)
CB123539 Liver .c 2428 to 2998 589 to 19   AAA Submitted on the opposite strand 571/571
(100 %)
0 diff
(100 %id)
AU151168   .c 2430 to 3000 565 to 1       565/572
(98 %)
12 diff
(98.0 %id)
AW879049 ovary .c 2431 to 2723 1 to 295       295/295
(100 %)
3 diff
(99.0 %id)
BQ286053 Pancreas, Purified pancreatic islet .c 2431 to 3002 572 to 1   fully sequenced,   572/572
(100 %)
1 diff
(99.9 %id)
BE825494 lung_normal .c 2433 to 2777 366 to 22       345/366
(94 %)
0 diff
(100 %id)
W38429 Pancreas, pancreatic islet .c 2435 to 2970 539 to 1       539/539
(100 %)
8 diff
(98.6 %id)
DB362726   .c 2435 to 2998 560 to 1       560/574
(97 %)
18 diff
(96.9 %id)
BF593790 brain, glioblastoma (pooled) .c 2438 to 3000 563 to 1       563/563
(100 %)
0 diff
(100 %id)
BE930206 placenta_normal .c 2440 to 2995 556 to 1       556/556
(100 %)
11 diff
(98.1 %id)
BE930145 placenta_normal .c 2450 to 2979 14 to 543       530/543
(97 %)
6 diff
(98.9 %id)
AU146392 whole embryo, mainly body .c 2450 to 2998 544 to 1       544/544
(100 %)
12 diff
(97.8 %id)
BE768951 prostate_tumor .c 2457 to 2743 33 to 320       288/320
(90 %)
6 diff
(98.2 %id)
AA581406 bulk tumor, colon .c 2457 to 2998 544 to 3       542/544
(99 %)
0 diff
(100 %id)
CX868407 embryonic stem .c 2459 to 3000 567 to 26   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 542/542
(100 %)
0 diff
(100 %id)
AW750245 breast .c 2461 to 2707 259 to 12       248/271
(91 %)
0 diff
(100 %id)
AW131437 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 2462 to 2828 368 to 1       368/368
(100 %)
1 diff
(99.8 %id)
AA641011 invasive tumor (cell line), Prostate .c 2466 to 2969 504 to 1       504/504
(100 %)
6 diff
(98.9 %id)
TI_151739959   .c 2472 to 3000 644 to 117   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 528/1050
(50 %)
31 diff
(97.1 %id)
BM673027 eye, optic nerve .c 2480 to 3000 539 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 521/521
(100 %)
2 diff
(99.7 %id)
BM768340 stomach .c 2483 to 2998 1 to 516       516/516
(100 %)
0 diff
(100 %id)
BM768370 stomach .c 2483 to 3001 1 to 519       519/532
(97 %)
1 diff
(99.9 %id)
AI718477 colon .c 2487 to 2996 510 to 1       510/510
(100 %)
0 diff
(100 %id)
AI569999 adenocarcinoma, Pancreas .c 2488 to 3001 514 to 1       514/514
(100 %)
0 diff
(100 %id)
BE675543 B-cell, chronic lymphotic leukemia .c 2488 to 3001 520 to 7       514/520
(98 %)
0 diff
(100 %id)
BE855927 brain, glioblastoma (pooled) .c 2488 to 3000 513 to 1       513/513
(100 %)
0 diff
(100 %id)
BG054874 brain, glioblastoma (pooled) .c 2488 to 3000 513 to 1       513/513
(100 %)
0 diff
(100 %id)
BI086129 astrocytoma grade IV, cell line, brain .c 2491 to 2944 472 to 16       457/630
(72 %)
0 diff
(100 %id)
DB569994 hypothalamus .c 2492 to 2997 1 to 507     Submitted on the opposite strand 507/507
(100 %)
7 diff
(98.7 %id)
TI_154148798   .c 2494 to 2997 584 to 81     Submitted on the opposite strand 504/504
(100 %)
0 diff
(100 %id)
AA919178 Kidney .c 2503 to 3000 508 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 498/498
(100 %)
1 diff
(99.8 %id)
DA435595 tongue, tumor tissue .c 2508 to 3065 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
BP294200 Liver .c 2519 to 2998 1 to 480   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 480/480
(100 %)
0 diff
(100 %id)
N25044 nose, olfactory epithelium .c 2520 to 3000 486 to 1       486/486
(100 %)
9 diff
(98.2 %id)
DB548083 hippocampus .c 2521 to 2996 1 to 477     Submitted on the opposite strand 477/479
(99 %)
5 diff
(99.0 %id)
N33416 melanocyte .c 2525 to 2998 476 to 1       476/477
(99 %)
2 diff
(99.6 %id)
AA946792 2 pooled tumors (clear cell type), Kidney .c 2525 to 2999 477 to 4       474/477
(99 %)
0 diff
(100 %id)
AA782595 parathyroid gland, parathyroid tumor .c 2526 to 3001 480 to 6       475/480
(98 %)
0 diff
(100 %id)
AW151992 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 2527 to 2999 501 to 29   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 473/473
(100 %)
1 diff
(99.8 %id)
BE855532 brain, glioblastoma (pooled) .c 2528 to 3000 473 to 1       473/473
(100 %)
0 diff
(100 %id)
AI762573 B-cell, chronic lymphotic leukemia .c 2533 to 3001 473 to 4       470/473
(99 %)
0 diff
(100 %id)
AW167142 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 2533 to 3000 468 to 1       468/468
(100 %)
0 diff
(100 %id)
AW167263 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 2533 to 2998 466 to 1       466/466
(100 %)
0 diff
(100 %id)
AA461449   .c 2534 to 2919 1 to 386     Submitted on the opposite strand 386/386
(100 %)
4 diff
(99.0 %id)
AI378161 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2534 to 2998 465 to 1       465/465
(100 %)
0 diff
(100 %id)
N36382 melanocyte .c 2535 to 3000 468 to 1       468/469
(99 %)
6 diff
(98.8 %id)
AI092710 parathyroid gland, parathyroid tumor .c 2535 to 2998 470 to 7       464/470
(98 %)
0 diff
(100 %id)
AI862616 B-cell, chronic lymphotic leukemia .c 2537 to 3001 465 to 1       465/465
(100 %)
2 diff
(99.6 %id)
AA461623   .c 2539 to 3109 571 to 1     Submitted on the opposite strand 571/595
(95 %)
0 diff
(100 %id)
AA526819 normal prostate, Prostate .c 2539 to 2989 452 to 1       452/462
(97 %)
6 diff
(98.8 %id)
BF476429 Prostate .c 2540 to 3000 458 to 1       458/458
(100 %)
2 diff
(99.6 %id)
DB565747 hypothalamus .c 2541 to 2998 1 to 458     Submitted on the opposite strand 458/458
(100 %)
9 diff
(98.1 %id)
AA513031 Ewing's sarcoma .c 2547 to 2858 7 to 318       312/318
(98 %)
1 diff
(99.7 %id)
DB517778 testis .c 2548 to 2998 1 to 451     Submitted on the opposite strand 451/453
(99 %)
1 diff
(99.8 %id)
AI858669 anaplastic oligodendroglioma, brain .c 2551 to 3001 451 to 1       451/451
(100 %)
0 diff
(100 %id)
AA805649 germinal center B cell .c 2553 to 3000 476 to 31   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 446/446
(100 %)
2 diff
(99.6 %id)
H06970 whole brain .c 2556 to 2998 471 to 9       463/481
(96 %)
0 diff
(100 %id)
AA281058 germinal center B cell .c 2557 to 3000 444 to 1       444/444
(100 %)
0 diff
(100 %id)
N21125 melanocyte .c 2562 to 3001 446 to 1       446/446
(100 %)
10 diff
(97.8 %id)
BM662129 eye, human retina .c 2565 to 3000 454 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 436/436
(100 %)
0 diff
(100 %id)
N34040 liver and spleen .c 2581 to 2998 422 to 4       419/422
(99 %)
0 diff
(100 %id)
N30018 melanocyte .c 2588 to 3000 416 to 1       416/417
(99 %)
3 diff
(99.3 %id)
AL531978 brain, fetal liver, Liver, neuroblastoma cells .c 2609 to 2926 353 to 37       861/982
(87 %)
40 diff
(96.0 %id)
N78704 lung .c 2612 to 3000 391 to 1   fully sequenced,   391/391
(100 %)
3 diff
(99.3 %id)
W81540 heart .c 2619 to 3007 390 to 1       390/390
(100 %)
2 diff
(99.5 %id)
R53000 whole brain .c 2631 to 2998 377 to 9       369/377
(97 %)
0 diff
(100 %id)
W15299 parathyroid gland, parathyroid tumor .c 2632 to 3000 371 to 1   fully sequenced,   371/371
(100 %)
5 diff
(98.7 %id)
W90537 liver and spleen .c 2662 to 3000 342 to 1   fully sequenced,   342/342
(100 %)
4 diff
(98.9 %id)
H48587 liver and spleen .c 2669 to 2978 311 to 1       311/311
(100 %)
3 diff
(99.1 %id)
Z41260 brain, total brain .c 2687 to 3000 314 to 1       314/314
(100 %)
0 diff
(100 %id)
H11514 whole brain .c 2739 to 2998 277 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 260/260
(100 %)
0 diff
(100 %id)
R45178 whole brain .c 2755 to 3000 265 to 15   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 251/251
(100 %)
5 diff
(98.1 %id)
AA007237 whole brain .c 2776 to 3001 228 to 3       226/228
(99 %)
0 diff
(100 %id)
AL545418 placenta, Placenta Cot 25-normalized .c 2917 to 3780 865 to 1   tiling clone,   865/867
(99 %)
3 diff
(99.7 %id)
N35967 melanocyte .c 3364 to 3813 462 to 1   tiling clone,   462/467
(98 %)
14 diff
(97.1 %id)
H81893 melanocyte .c 3466 to 3800 341 to 1   tiling clone,   341/342
(99 %)
6 diff
(98.3 %id)
AK299140   .d 1 to 1578 2 to 1579 exact tiling clone,   1579/1579
(100 %)
3 diff
(99.9 %id)
AU125438   .d 1 to 785 2 to 787   capped   786/787
(99 %)
6 diff
(99.3 %id)
DB363071   .d 1921 to 2333 413 to 1   tiling clone,   413/416
(99 %)
4 diff
(99.1 %id)
DA667018   .e 1 to 554 2 to 555   tiling clone, capped   554/554
(100 %)
0 diff
(100 %id)
DA448706 tongue, tumor tissue .e 69 to 608 2 to 541   tiling clone, capped   540/540
(100 %)
1 diff
(99.9 %id)
DB314133 tongue, tumor tissue .e 2575 to 3095 522 to 1   tiling clone,   522/522
(100 %)
1 diff
(99.9 %id)
DA439337 tongue, tumor tissue .f 1 to 553 2 to 554   tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
DA285743 corpus callosum .f 5 to 503 2 to 501   capped   500/500
(100 %)
1 diff
(99.8 %id)
DB313588 tongue, tumor tissue .f 1951 to 2498 550 to 1   tiling clone,   550/552
(99 %)
2 diff
(99.7 %id)
CX762983 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .g 1 to 762 1 to 761   tiling clone, Submitted on the opposite strand 761/761
(100 %)
1 diff
(99.9 %id)
AF339785   .g 681 to 2862 2181 to 1   tiling clone, Submitted on the opposite strand 2181/2195
(99 %)
7 diff
(99.7 %id)
AI904133 breast .g 1258 to 1579 39 to 358       320/358
(89 %)
6 diff
(98.4 %id)
BU078313 Pancreas, Purified pancreatic islet .g 2185 to 2577 1 to 393   fully sequenced,   393/393
(100 %)
3 diff
(99.3 %id)
BU078150 Pancreas, Purified pancreatic islet .g 2185 to 2787 1 to 603       603/603
(100 %)
0 diff
(100 %id)
BF360124 marrow .g 2327 to 2612 28 to 312       285/312
(91 %)
8 diff
(97.5 %id)
BX115265 liver and spleen .g 2421 to 2862 1 to 444   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 444/444
(100 %)
5 diff
(98.9 %id)
H93707 liver and spleen .g 2439 to 2862 428 to 1       428/428
(100 %)
6 diff
(98.6 %id)
BU078073 Pancreas, Purified pancreatic islet .g 2547 to 2861 315 to 1   fully sequenced,   315/315
(100 %)
0 diff
(100 %id)
R10140 liver and spleen .g 2549 to 2851 303 to 1       303/305
(99 %)
2 diff
(99.4 %id)
CN258114 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 2581 to 3274 1 to 694   tiling clone,   694/694
(100 %)
3 diff
(99.6 %id)
BX497988 Liver .g 2696 to 3156 1 to 463       463/463
(100 %)
4 diff
(99.2 %id)
AA324704 brain, cerebellum .g 3088 to 3448 1 to 361   tiling clone,   361/361
(100 %)
1 diff
(99.8 %id)
DA875045 Prostate .h 1 to 574 2 to 575   tiling clone, capped   574/574
(100 %)
2 diff
(99.7 %id)
CR996812 T-Lymphocytes .h 346 to 1106 1 to 762   tiling clone,   762/762
(100 %)
2 diff
(99.8 %id)
CA393566 eye, RPE/choroid .h 667 to 1172 1 to 506 exact tiling clone,   506/506
(100 %)
1 diff
(99.9 %id)
DB452224 testis .i-u 1 to 496 5 to 501 exact tiling clone,   501/501
(100 %)
4 diff
(99.3 %id)
EH348503   .i-u 301 to 361 1 to 60       60/63
(95 %)
2 diff
(96.9 %id)
BG542300 lung .j 1 to 822 1 to 818 L74W tiling clone,   818/837
(97 %)
27 diff
(96.8 %id)
BF086227 placenta_normal .j 535 to 992 466 to 7       460/466
(98 %)
0 diff
(100 %id)
FN128615 breast carcinoma .j 539 to 637 1 to 94       94/101
(93 %)
6 diff
(94.1 %id)
AI188164   .j 540 to 987 455 to 7       449/459
(97 %)
0 diff
(100 %id)
BQ351116 head_neck .j 546 to 753 7 to 221       215/221
(97 %)
6 diff
(97.3 %id)
AI039418   .j 546 to 997 458 to 7       452/458
(98 %)
0 diff
(100 %id)
AI200222 placenta .j 546 to 989 445 to 1       445/445
(100 %)
2 diff
(99.6 %id)
AI281087 adenocarcinoma, colon .j 553 to 990 441 to 4       438/441
(99 %)
0 diff
(100 %id)
AW408809 lymph .j 553 to 987 441 to 7     Submitted on the opposite strand 435/441
(98 %)
0 diff
(100 %id)
EH334174   .j 554 to 615 1 to 62       62/62
(100 %)
0 diff
(100 %id)
DA959570 Spleen .j 555 to 1054 2 to 501   tiling clone, capped   500/500
(100 %)
0 diff
(100 %id)
EB362303 eye, lens .j 557 to 989 433 to 1       433/433
(100 %)
2 diff
(99.6 %id)
BQ029534 lung, Metastatic Chondrosarcoma .j 558 to 989 450 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 432/432
(100 %)
1 diff
(99.8 %id)
AI619973 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .j 565 to 987 441 to 21   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 421/421
(100 %)
8 diff
(98.1 %id)
AI283857 adenocarcinoma, colon .j 566 to 988 424 to 1       424/424
(100 %)
1 diff
(99.8 %id)
DB528420 hippocampus .j 572 to 985 1 to 413     Submitted on the opposite strand 413/415
(99 %)
12 diff
(97.2 %id)
DB537499 hippocampus .j 577 to 987 1 to 414     Submitted on the opposite strand 414/414
(100 %)
12 diff
(97.2 %id)
H97350 melanocyte .j 577 to 989 424 to 1       424/425
(99 %)
13 diff
(97.0 %id)
AA192353   .j 577 to 987 424 to 11   AAA Submitted on the opposite strand 414/448
(92 %)
13 diff
(97.1 %id)
AI564460 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j 578 to 989 427 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 412/412
(100 %)
2 diff
(99.6 %id)
DB507523 testis .j 580 to 987 1 to 407     Submitted on the opposite strand 407/408
(99 %)
4 diff
(99.1 %id)
N69901.
matches multiple genes
lung .j 584 to 987 408 to 3     also hits gene SNHG8andSNORA24 406/408
(99 %)
0 diff
(100 %id)
DB539046 hippocampus .j 587 to 987 1 to 400     Submitted on the opposite strand 400/400
(100 %)
13 diff
(96.8 %id)
AA827724 germinal center B cell .j 588 to 990 411 to 9       403/411
(98 %)
0 diff
(100 %id)
BG029320 Bone, osteosarcoma, cell line .j 595 to 989 1 to 394   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 394/394
(100 %)
1 diff
(99.8 %id)
BF093406 testis_normal .j 597 to 985 18 to 405       388/405
(95 %)
6 diff
(98.6 %id)
AI093083 heart .j 601 to 988 389 to 2       388/389
(99 %)
0 diff
(100 %id)
CR610999 Placenta Cot 25-normalized .j 604 to 990 1 to 387       387/387
(100 %)
0 diff
(100 %id)
AL547537 placenta, Placenta Cot 25-normalized .j 604 to 934 338 to 8   fully sequenced,   331/338
(97 %)
0 diff
(100 %id)
AL547571 placenta, Placenta Cot 25-normalized .j 604 to 990 1 to 387   fully sequenced,   387/387
(100 %)
0 diff
(100 %id)
AA724882 parathyroid gland, parathyroid tumor .j 606 to 990 390 to 6       385/390
(98 %)
0 diff
(100 %id)
AI281391 follicular lymphoma, lymph node .j 606 to 989 396 to 13   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 384/384
(100 %)
0 diff
(100 %id)
AI247184 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j 606 to 990 385 to 1       385/385
(100 %)
0 diff
(100 %id)
BE219822 carcinoid, lung .j 608 to 959 1 to 352     Submitted on the opposite strand 352/352
(100 %)
3 diff
(99.2 %id)
BE220290 carcinoid, lung .j 608 to 980 1 to 373     Submitted on the opposite strand 373/373
(100 %)
0 diff
(100 %id)
AA812591   .j 609 to 988 382 to 4       379/382
(99 %)
0 diff
(100 %id)
AA506283 colon .j 610 to 987 378 to 1       378/378
(100 %)
1 diff
(99.8 %id)
AI026021 parathyroid gland, parathyroid tumor .j 610 to 990 386 to 6       381/386
(98 %)
0 diff
(100 %id)
BF089707 head_neck .j 613 to 987 1 to 376   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 376/376
(100 %)
6 diff
(98.5 %id)
AI022901 parathyroid gland, parathyroid tumor .j 614 to 990 382 to 6       377/382
(98 %)
0 diff
(100 %id)
AI074910 senescent fibroblast .j 614 to 987 377 to 6       372/377
(98 %)
0 diff
(100 %id)
AA721737 germinal center B cell .j 616 to 987 389 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 372/372
(100 %)
2 diff
(99.5 %id)
AI242156 liver and spleen .j 628 to 987 361 to 2       360/361
(99 %)
0 diff
(100 %id)
AA864820 Kidney, kidney tumor .j 634 to 989 356 to 1       356/356
(100 %)
0 diff
(100 %id)
BF447342 sympathetic trunk .j 637 to 989 365 to 13   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 353/355
(99 %)
2 diff
(99.5 %id)
AI122812   .j 641 to 988 351 to 4       348/351
(99 %)
0 diff
(100 %id)
AA970422 2 pooled tumors (clear cell type), Kidney .j 645 to 990 348 to 3       346/348
(99 %)
0 diff
(100 %id)
AI042384 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 650 to 987 344 to 7       338/344
(98 %)
0 diff
(100 %id)
EC529032 Prostate .j 665 to 783 1 to 119       119/119
(100 %)
0 diff
(100 %id)
H46585 breast .j 666 to 953 291 to 1       291/293
(99 %)
6 diff
(98.0 %id)
BE928289 colon .j 673 to 932 302 to 39       264/317
(83 %)
0 diff
(100 %id)
EC578054 Prostate .j 673 to 798 1 to 124       124/124
(100 %)
3 diff
(97.6 %id)
BG959872 colon .j 676 to 938 5 to 266       262/266
(98 %)
6 diff
(97.8 %id)
BG959874 colon .j 676 to 989 4 to 315   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 312/315
(99 %)
7 diff
(97.8 %id)
T34122 blood, white blood cells .j 677 to 989 314 to 1     Submitted on the opposite strand 314/321
(97 %)
3 diff
(99.1 %id)
BG959200 colon .j 681 to 956 1 to 274       274/274
(100 %)
8 diff
(97.1 %id)
BG959264 colon .j 690 to 887 202 to 5       198/202
(98 %)
0 diff
(100 %id)
BG959878 colon .j 690 to 904 219 to 5       215/219
(98 %)
0 diff
(100 %id)
BG959882 colon .j 690 to 884 194 to 4       191/194
(98 %)
0 diff
(100 %id)
BG959890 colon .j 690 to 967 281 to 5       277/281
(98 %)
0 diff
(100 %id)
CV317438 colon .j 698 to 986 1 to 291       291/291
(100 %)
32 diff
(89.1 %id)
BG959865 colon .j 701 to 983 286 to 4       283/286
(98 %)
0 diff
(100 %id)
AI349486 lung .j 701 to 996 296 to 1       296/296
(100 %)
1 diff
(99.7 %id)
BE697933 colon .j 704 to 991 295 to 8       288/295
(97 %)
0 diff
(100 %id)
AA778473   .j 705 to 990 289 to 4       286/289
(98 %)
0 diff
(100 %id)
BG959254 colon .j 707 to 951 1 to 244       244/244
(100 %)
8 diff
(96.8 %id)
DB519417 testis .j 712 to 987 1 to 276     Submitted on the opposite strand 276/276
(100 %)
6 diff
(97.9 %id)
BU183164 melanotic melanoma, skin .j 716 to 1506 1 to 795   tiling clone,   795/885
(89 %)
7 diff
(99.3 %id)
AI524605 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j 721 to 989 306 to 38   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 269/269
(100 %)
13 diff
(95.2 %id)
AI584037 adenocarcinoma, Pancreas .j 729 to 987 262 to 3       260/262
(99 %)
0 diff
(100 %id)
H28653 breast .j 753 to 989 237 to 1       237/237
(100 %)
1 diff
(99.6 %id)
AI262576 Kidney .j 759 to 990 236 to 5       232/236
(98 %)
0 diff
(100 %id)
AA551265 adrenal adenoma, adrenal gland .j 766 to 990 225 to 1       225/225
(100 %)
0 diff
(100 %id)
AW008128 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j 767 to 990 225 to 2       224/225
(99 %)
0 diff
(100 %id)
R93308 liver and spleen .j 775 to 988 215 to 2       214/215
(99 %)
0 diff
(100 %id)
BQ029616 lung, Metastatic Chondrosarcoma .j 775 to 989 233 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 215/215
(100 %)
4 diff
(98.2 %id)
BM830630 stomach .j 800 to 1262 1 to 463   tiling clone,   463/463
(100 %)
0 diff
(100 %id)
AA600307   .j 804 to 989 196 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 186/186
(100 %)
1 diff
(99.5 %id)
AI658998 Prostate .j 808 to 989 182 to 1       182/182
(100 %)
0 diff
(100 %id)
AA778488   .j 809 to 989 181 to 1       181/181
(100 %)
4 diff
(97.8 %id)
DR977834 brain .j 818 to 987 1 to 169   AAA Submitted on the opposite strand 169/169
(100 %)
6 diff
(96.5 %id)
CD177025 embryonic trophoblasts, made from WA01 stemcells .j 821 to 987 21 to 187   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 167/187
(89 %)
6 diff
(96.8 %id)
C06233   .j 822 to 981 161 to 6       156/177
(88 %)
0 diff
(100 %id)
BX370067 Placenta Cot 25-normalized .j 823 to 990 1 to 166       166/171
(97 %)
3 diff
(98.3 %id)
BE327827 malignant melanoma, metastatic to lymphnode, skin .j 851 to 989 150 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 139/139
(100 %)
6 diff
(95.7 %id)
AI364933 B-cell, chronic lymphotic leukemia .j 1316 to 1803 490 to 3   tiling clone,   488/490
(99 %)
0 diff
(100 %id)
BF377894 testis_normal .j 1326 to 1699 393 to 22       372/394
(94 %)
0 diff
(100 %id)
AI445393 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j 1405 to 1803 400 to 3       398/400
(99 %)
0 diff
(100 %id)
AA759097   .j 1414 to 1803 391 to 2       390/391
(99 %)
0 diff
(100 %id)
AI377201 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 1438 to 1802 365 to 1       365/365
(100 %)
1 diff
(99.8 %id)
AI015332   .j 1481 to 1803 325 to 3       323/325
(99 %)
0 diff
(100 %id)
AA250895 germinal center B cell .j 1570 to 1943 1 to 373       373/373
(100 %)
3 diff
(99.2 %id)
AA251999 germinal center B cell .j 1616 to 2030 1 to 415       415/415
(100 %)
0 diff
(100 %id)
AW239508 lung, cell line .j 1647 to 1977 331 to 1     Submitted on the opposite strand 331/331
(100 %)
0 diff
(100 %id)
AI203246 pooled germ cell tumors .j 1652 to 2060 409 to 1       409/409
(100 %)
0 diff
(100 %id)
AI917077 pooled germ cell tumors .j 1652 to 2074 427 to 5   tiling clone,   423/427
(99 %)
5 diff
(98.9 %id)
BM715094 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .j 1890 to 2420 1 to 531   tiling clone,   531/531
(100 %)
1 diff
(99.9 %id)
BF313067 brain, neuroblastoma .j 1922 to 2683 1 to 755   tiling clone,   755/930
(81 %)
16 diff
(98.3 %id)
CA432492 cell lines, Chondrosarcoma .j 2218 to 2946 749 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 731/731
(100 %)
4 diff
(99.5 %id)
AW966930   .j 2243 to 2940 705 to 8     Submitted on the opposite strand 698/705
(99 %)
0 diff
(100 %id)
AW967689   .j 2299 to 2947 649 to 1     Submitted on the opposite strand 649/649
(100 %)
8 diff
(98.8 %id)
BF934505 nervous_tumor .j 2300 to 2658 359 to 1     Submitted on the opposite strand 359/360
(99 %)
2 diff
(99.5 %id)
AW967548   .j 2347 to 2947 601 to 1   tiling clone, Submitted on the opposite strand 601/604
(99 %)
2 diff
(99.7 %id)
AW967684   .j 2406 to 2947 540 to 1     Submitted on the opposite strand 540/540
(100 %)
25 diff
(95.4 %id)
AW183096 pooled .j 2442 to 2950 511 to 3   tiling clone,   509/511
(99 %)
0 diff
(100 %id)
BU739998 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .j 2444 to 2946 523 to 21       503/523
(96 %)
0 diff
(100 %id)
AW444507   .j 2459 to 2946 505 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 488/492
(99 %)
0 diff
(100 %id)
AW271640 Kidney .j 2492 to 2946 455 to 1       455/455
(100 %)
1 diff
(99.8 %id)
AI816880 2 pooled tumors (clear cell type), Kidney .j 2556 to 2947 393 to 3       391/393
(99 %)
0 diff
(100 %id)
AA825667 germinal center B cell .j 2559 to 2948 399 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 389/389
(100 %)
1 diff
(99.8 %id)
AA251771 germinal center B cell .j 2622 to 2948 327 to 1       327/327
(100 %)
0 diff
(100 %id)
AA250836 germinal center B cell .j 2625 to 2948 324 to 1       324/324
(100 %)
0 diff
(100 %id)
BG059748 brain, glioblastoma without EGFR amplification .j 2673 to 2946 273 to 1       273/273
(100 %)
5 diff
(98.2 %id)
AA294894 Pancreas .k-u 1 to 381 12 to 393 N2I tiling clone,   382/393
(97 %)
10 diff
(97.5 %id)
BG745682 Spleen .k-u 145 to 487 1 to 343   tiling clone,   343/594
(57 %)
2 diff
(99.7 %id)
AI245552 Kidney .k-u 739 to 1177 438 to 1   tiling clone,   438/438
(100 %)
1 diff
(99.8 %id)
BG057393 blood, lymphocyte .k-u 750 to 1252 503 to 1   tiling clone,   503/503
(100 %)
0 diff
(100 %id)
CX787940 human embryonic stem cells .k-u 1169 to 2022 11 to 863   tiling clone,   853/863
(98 %)
6 diff
(99.4 %id)
BG745966 Spleen .k-u 1632 to 2356 749 to 14       736/1161
(63 %)
27 diff
(97.7 %id)
AA192455   .k-u 1680 to 2385 706 to 1   tiling clone,   706/726
(97 %)
57 diff
(92.2 %id)
TI_154043462   .k-u 1806 to 2379 660 to 87   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 574/977
(58 %)
1 diff
(99.9 %id)
AW294111   .k-u 1847 to 2396 552 to 1   tiling clone,   552/552
(100 %)
3 diff
(99.5 %id)
AA707196.
matches multiple genes
liver and spleen .k-u 1863 to 2378 516 to 1     Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base), also hits gene FLT1 516/516
(100 %)
0 diff
(100 %id)
AI924499 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .k-u 2004 to 2385 382 to 1       382/700
(54 %)
5 diff
(99.3 %id)
BM716492 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .l 1 to 656 1 to 656   tiling clone, to resequence,   656/656
(100 %)
1 diff
(99.9 %id)
BX113958 Kidney .l 629 to 1103 12 to 486   tiling clone,   475/486
(97 %)
6 diff
(98.8 %id)
BU738547 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .l 1675 to 2235 575 to 17   tiling clone, to resequence,   559/575
(97 %)
0 diff
(100 %id)
BI012311 lung_normal .m 1 to 413 33 to 434   tiling clone,   402/434
(92 %)
9 diff
(98.0 %id)
BP210119 cerebellum .m 369 to 951 8 to 590   tiling clone,   583/587
(99 %)
4 diff
(99.4 %id)
BF589872 sciatic nerve .m 795 to 1483 688 to 3   tiling clone,   686/688
(99 %)
0 diff
(100 %id)
DA344024 substantia nigra .n 1 to 582 2 to 583   tiling clone, capped   582/582
(100 %)
2 diff
(99.7 %id)
DA252319 caudate nucleus .n 126 to 719 2 to 595   tiling clone, capped   594/594
(100 %)
1 diff
(99.9 %id)
TI_153955991   .o-u 1 to 668 78 to 752 S28E W29L R30E I31N A32R ... tiling clone,   675/1008
(66 %)
29 diff
(97.2 %id)
DB188819 liver, tumor tissue .o-u 105 to 681 2 to 578 exact tiling clone, capped   577/577
(100 %)
0 diff
(100 %id)
DB030906 testis .q 1 to 544 2 to 545   tiling clone, capped   544/544
(100 %)
0 diff
(100 %id)
AK026896 colon Gene STK24, variant not shown       available from FLJ, AAA This clone was ignored    
AK297583 brain Gene STK24, variant not shown         Suspected internal deletion, this clone was ignored    
BG003890 placenta_normal Gene STK24, variant not shown              
AI017638 Kidney Gene STK24, variant not shown         This clone was ignored    
BE785550 large cell carcinoma, lung Gene STK24, variant not shown         Suspected internal deletion, this clone was ignored    
BP378420 uterus Gene STK24, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j, .k-u, .l, .m, .n, .o-u, .p-u, .q Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI